COVID-19 outcomes in patients with cancer: Findings from the University of California health system database.
Daniel H KwonJose CadenaSam NguyenKwan Ho Ryan ChanBraden SoperAmy L GryshukJulian C HongPriyadip RayFranklin W HuangPublished in: Cancer medicine (2022)
In this large, diverse cohort, cancer was associated with a decreased risk of SARS-CoV-2 positivity. Patients with BCR/ABL-negative myeloproliferative neoplasm or receiving methotrexate or venetoclax may be at increased risk of hospitalization following SARS-CoV-2 infection. Mechanistic and comparative studies are needed to validate findings.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- tyrosine kinase
- chronic myeloid leukemia
- papillary thyroid
- coronavirus disease
- acute lymphoblastic leukemia
- squamous cell
- high dose
- low grade
- case control
- lymph node metastasis
- emergency department
- chronic lymphocytic leukemia
- adverse drug
- childhood cancer
- low dose
- skeletal muscle
- insulin resistance
- weight loss